This Time Adam F. Is Correct

[realisticview]

MNKD will start to be valued as a middle-aged to mature biotech and no longer a hyped youngster with untold potential. The balance sheet is critical, particularly the number  of fully-diluted outstanding shares which approximates 450 million, approximately triple the amount prior to the last CRL. And then there's the long term debt. And then there's the cash burn. I believe we'll see another round of dilutive financing, and it better be soon with the way the pps is tanking down towards the open gap at $4. As I said previously, I believe mnkd is headed for the $3's.

[garrett]

I agree. Mannkind is no longer a binary event driven stock with momentum to the upside. Earnings will now drive the stock up but only when they are reported. In the meantime, I think selling covered calls makes for a good strategy until then.

[novafett]

Yahooo!!

[joeypotsandpans]

You never answered my question:

Ahh, my friend with the pre Adcom "gap" that needs to filled....hope you don't hold your breath waiting for that entry point "in the $3's" but taking your stance of "Would not put it into MNKD" list me one stock you would put it into and we'll compare it one year from now with MNKD, that should be fairly easy for you. TIA

Read more: mnkd.proboards.com/thread/1165/100k-today-where-put#ixzz3ANV5CJXy

[realisticview]

Joey, I don't "pick" stocks. I sold all my MNKD holdings at mkt open on Monday for $9.76. Your attempts to read MNKD's chart using TA have been noble - there now has been a high volume reversal breaking through a support level at $8.00 Where is your TA analysis of this - and where is your analysis of where MNKD is likely going? Or do you only give TA analysis to support your long bias? Regarding your challenge, I would look at ARNA - the stock has taken a beating and they sell an anti-fat drug (big target audience - literally and figuratively). Good Luck.

[joeypotsandpans]

Aug 14, 2014 10:17:19 GMT -5 realisticview said:

Joey, I don't "pick" stocks. I sold all my MNKD holdings at mkt open on Monday for $9.76. Your attempts to read MNKD's chart using TA have been noble - there now has been a high volume reversal breaking through a support level at $8.00 Where is your TA analysis of this - and where is your analysis of where MNKD is likely going? Or do you only give TA analysis to support your long bias? Regarding your challenge, I would look at ARNA - the stock has taken a beating and they sell an anti-fat drug (big target audience - literally and figuratively). Good Luck.

If you read my response to DBC and Chicagpete, I stated that it broke the support level and next support was at the 200d ma @ 6.77 (at the time), the 200d is still rising so when/if that gets tested would be where I would add or initiate for wanna be or current longs. I also said I like to look at the weekly charts as well and would like to see how it finishes the week. I do the TA for those that are looking for ranges and entry points....I am long term invested in this company, you can agree and think that "Adam is right this time" (which I totally disagree with....but you can think he is once out of a dozen malevolent articles or so....it was fun to watch him scramble during the Adcom votes). Obviously as to where it is going, I anticipate a lot higher from here one year from now as I have stated...wasn't asking for a "pick" rather giving you the rest of the market to choose a company that you believe will outperform this one a year from now. So we will go with ARNA as your "paired" trade for one year out (my thought on that one is ARNA has to compete with VVUS, MNKD currently does not have a competitor for it's ultra rapid acting insulin) we will see how it plays out

[joeypotsandpans]

For archiving purposes only

MNKD 7.05

ARNA 4.39

Btw, anyone else that has a potentially better choice for ROI on year from ow feel free to respond will be fun to look back in your year

[otherottawaguy]

Paying off my credit cards, earns me a cool 21%.